Insider Transactions in Q1 2026 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2026
|
Dietmar Berger Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,944
-42.53%
|
$840,224
$121.6 P/Share
|
|
Jan 02
2026
|
Dietmar Berger Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,326
+50.0%
|
-
|